SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,947 | -55.0% | 522 | -57.7% | 0.01% | -59.3% |
| Q4 2022 | $160,031 | -4.7% | 1,235 | -18.9% | 0.03% | -22.9% |
| Q3 2022 | $168,000 | +14.3% | 1,522 | -22.1% | 0.04% | +25.0% |
| Q2 2022 | $147,000 | -34.4% | 1,955 | -31.7% | 0.03% | -31.7% |
| Q1 2022 | $224,000 | -13.2% | 2,863 | 0.0% | 0.04% | -18.0% |
| Q4 2021 | $258,000 | -5.8% | 2,863 | -3.3% | 0.05% | -13.8% |
| Q3 2021 | $274,000 | +16.1% | 2,961 | -2.3% | 0.06% | +16.0% |
| Q2 2021 | $236,000 | +95.0% | 3,032 | +86.1% | 0.05% | +85.2% |
| Q1 2021 | $121,000 | +31.5% | 1,629 | +202.8% | 0.03% | +17.4% |
| Q4 2020 | $92,000 | -34.8% | 538 | -46.3% | 0.02% | -46.5% |
| Q3 2020 | $141,000 | -11.9% | 1,001 | 0.0% | 0.04% | -20.4% |
| Q2 2020 | $160,000 | +63.3% | 1,001 | 0.0% | 0.05% | +35.0% |
| Q1 2020 | $98,000 | -26.3% | 1,001 | -3.4% | 0.04% | -41.2% |
| Q4 2019 | $133,000 | – | 1,036 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |